Immunoblot analysis revealed a downregulation of phosphor-MET, MET, VEGFR2, c-MYC, and Snail in tepotinib-treated GC cell lines, with the exception of MET-negative Kato III cells (Figure 5 and Figure S2). The gene discussed is MYC; the disease is gastric cancer.